Infection and Drug Resistance (Apr 2025)

Analysis of Antifungal Drug Resistance Among Candida Spp. and Other Pathogenic Yeasts Isolated from Patients in Eastern Poland: Diagnostic Problems

  • Olender A,
  • Bogut A,
  • Dąbrowski W,
  • Pietrzak DJ,
  • Szukała M,
  • Wójtowicz-Bobin M,
  • Kubera D,
  • Dróżdż A,
  • Stepulak A,
  • Gagoś M

Journal volume & issue
Vol. Volume 18
pp. 2187 – 2199

Abstract

Read online

Alina Olender,1 Agnieszka Bogut,1 Wojciech Dąbrowski,2 Daniel Jarosław Pietrzak,2 Magdalena Szukała,2 Małgorzata Wójtowicz-Bobin,1 Dominika Kubera,3 Agnieszka Dróżdż,3 Andrzej Stepulak,4 Mariusz Gagoś3,4 1Chair and Department of Medical Microbiology, Medical University of Lublin, Lublin, Poland; 2First Department of Anaesthesiology and Intensive Therapy Medical University of Lublin, Lublin, Poland; 3Faculty of Physics and Applied Computer Science, AGH University of Kraków, Kraków, Poland; 4Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, PolandCorrespondence: Agnieszka Bogut, Chair and Department of Medical Microbiology, Collegium Universum, Medical University of Lublin, Chodźki 1 Street, Lublin, 20-093, Poland, Tel +48814486410, Email [email protected]: The profile of Candida species and their sensitivity to antifungal drugs isolated from patients in Eastern Poland were analyzed. Identification and drug resistance interpretation issues for clinically significant rare species were investigated.Methods: A total of 197 yeast isolates were analyzed. Fungal identification was conducted using biochemical tests and MALDI-TOF. Minimum inhibitory concentrations (MICs) were determined for amphotericin B, fluconazole, itraconazole, voriconazole, isavuconazole, posaconazole, caspofungin, micafungin, and anidulafungin. Interpretation of results was based on the EUCAST, CLSI recommendations, and available literature.Results: The following species were identified: Candida albicans (n=78), C. glabrata (Nakaseomyces glabrata) (n=30), C. dubliniensis (n=23), C. krusei (Pichia kudriavzevii) (n=13), C. parapsilosis (n=13), C. tropicalis (n=7), C. kefyr (Kluyveromyces marxianus) (n=6), C. lusitaniae (Clavispora lusitaniae) (n=6), C. lipolytica (Yarrowia lipolytica) (n=3), C. famata (Debaryomyces hansenii) (n=2), C. intermedia (n=2), C. guillermondii (Meyerozyma guilliermondii) (n=2), C. ciferrii (n=1), C. orthopsilosis (n=1), C. pelliculosa (Wickerhamomyces anomalus) (n=1), C. shehatae (n=1), C. fabianii (Cyberlindnera fabianii) (n=1), Cryptococcus humicola (Vanrija humicola) (n=4), and Saccharomyces cerevisiae (n=3). The highest percentage of resistant strains was reported for C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, and C. lusitaniae.Conclusion: Among the studied isolates, rare Candida species were identified. Their identification in routine diagnostics can be challenging, necessitating the use of MALDI-TOF MS. The wide spectrum of isolated species may complicate the establishment of a targeted antifungal therapy due to the lack of reference MIC ranges for the interpretation of antibiograms. Gradient strips are an accurate, reproducible, and convenient method for MIC determination.Keywords: antifungal resistance, Candida, rare Candida species, antifungal susceptibility testing

Keywords